Multicenter phase II study of mogamulizumab (KW-0761), a defucosylated anti-CC chemokine receptor 4 antibody, in patients with relapsed peripheral T-cell lymphoma and cutaneous T-cell lymphoma

Michinori Ogura, Takashi Ishida, Hiroshi Inagaki, Kazuhito Yamamoto, Ryuzo Ueda, Kiyohiko Hatake, Kensei Tobinai, Shiro Akinaga, Masafumi Taniwaki, Kiyoshi Ando, Katsuya Fujimoto, Toshihiro Miyamoto, Naokuni Uike, Kazuo Tamura, Mitsune Tanimoto, Kunihiro Tsukasaki, Masao Tomonaga, Kenichi Ishizawa, Junji Suzumiya

Research output: Contribution to journalArticlepeer-review

225 Citations (Scopus)

Fingerprint Dive into the research topics of 'Multicenter phase II study of mogamulizumab (KW-0761), a defucosylated anti-CC chemokine receptor 4 antibody, in patients with relapsed peripheral T-cell lymphoma and cutaneous T-cell lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences